This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Investigations

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Imaging for suspected meningioma/glioma

  • standard structural MRI (defined as T2 weighted, FLAIR, DWI series and T1 pre- and post-contrast volume) should be offered as the initial diagnostic test for suspected glioma, unless MRI is contraindicated
    • refer people with a suspected glioma to a specialist multidisciplinary team at first radiological diagnosis for management of their tumour
      • advanced MRI techniques, such as MR perfusion and MR spectroscopy, should be considered to assess the potential of a high-grade transformation in a tumour appearing to be low grade on standard structural MRI

  • consider CT imaging for meningioma (if not already performed) to assess bone involvement if this is suspected.

Use of molecular markers to determine prognosis or guide treatment for glioma

Report all glioma specimens according to the latest version of theWorld Health Organization (WHO) classification. As well as histopathological assessment, include molecular markers such as:

  • IDH1 and IDH2 mutations
  • ATRX mutations to identify IDH mutant astrocytomas and glioblastomas
  • 1p/19q codeletion to identify oligodendrogliomas
  • histone H3.3 K27M mutations in midline gliomas
  • BRAF fusion and gene mutation to identify pilocytic astrocytoma

Test all high-grade glioma specimens for MGMT promoter methylation to inform prognosis and guide treatment.

Consider testing IDH-wildtype glioma specimens for TERT promoter mutations to inform prognosis

Notes:

  • chest X -ray } helps establish whether a primary tumour
  • ESR/CRP } or metastasis
  • skull X -ray - look for signs of raised intracranial pressure, e.g. suture separation; calcification, e.g. hyperostosis of adjacent bone in meningioma; erosion of posterior clinoids, e.g. craniopharyngioma; osteolytic lesions, e.g. dermoid, epidermoid, meningiomas
  • angiography - may help differentiate certain tumours, e.g. meningiomas, secondary tumours and gliomas; also used to exclude arteriovenous malformations / aneurysms biopsy
  • burr hole, stereotactic, open with decompression
  • other tumour markers - alpha-fetoprotein and human chorionic gonadotrophin are reliable markers for germinomas

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.